IMMU-18. Targeting Antigen Presenting Cells to improve virotherapy efficacy in Diffuse Midline Gliomas

With a 2-year survival less than 20%, Diffuse Intrinsic Pontine Glioma (DIPG) is the principal cause of pediatric death. Despite recent advances in the current treatments, the outcome for children with DIPGs remains dismal. Since the approval of T-VEC for melanoma by the FDA, oncolytic adenoviruses...

Descripción completa

Detalles Bibliográficos
Autores principales: Labiano, Sara, Marco-Sanz, Javier, Laspidea, Virginia, Garcia-Moure, Marc, Puigdelloses, Montserrat, Ausejo, Iker, Hernández-Osuna, Reyes, Becher, Oren, Patiño-Garcia, Ana, Gomez-Manzano, Candelaria, Fueyo, Juan, Alonso, Marta M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Immunotherapy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9164981/
http://dx.doi.org/10.1093/neuonc/noac079.311

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9164981/
http://dx.doi.org/10.1093/neuonc/noac079.311

Ejemplares similares